BMP signaling in vascular biology and dysfunction

AG de Vinuesa, S Abdelilah-Seyfried, P Knaus… - Cytokine & growth factor …, 2016 - Elsevier
The vascular system is critical for developmental growth, tissue homeostasis and repair but
also for tumor development. Bone morphogenetic protein (BMP) signaling has recently …

BMP9 and BMP10: Two close vascular quiescence partners that stand out

A Desroches‐Castan, E Tillet… - Developmental …, 2022 - Wiley Online Library
Bone morphogenetic proteins (BMPs) are dimeric transforming growth factor ß (TGFß) family
cytokines that were first described in bone and cartilage formation but have since been …

Selective BMP-9 inhibition partially protects against experimental pulmonary hypertension

L Tu, A Desroches-Castan, C Mallet, L Guyon… - Circulation …, 2019 - Am Heart Assoc
Rationale: Although many familial cases of pulmonary arterial hypertension exhibit an
autosomal dominant mode of inheritance with the majority having mutations in essential …

The role of BMPs in endothelial cell function and dysfunction

LA Dyer, X Pi, C Patterson - Trends in Endocrinology & Metabolism, 2014 - cell.com
The bone morphogenetic protein (BMP) family of proteins has a multitude of roles
throughout the body. In embryonic development, BMPs promote endothelial specification …

Apelin and its receptor APJ in cardiovascular diseases

XH Yu, ZB Tang, LJ Liu, H Qian, SL Tang, DW Zhang… - Clinica Chimica …, 2014 - Elsevier
Apelin is an adipokine that has been identified as an endogenous ligand for the orphan
receptor APJ. Apelin and APJ are expressed in a diverse range of tissues with particular …

Apelin/APJ system: a novel promising therapy target for pathological angiogenesis

L Wu, L Chen, L Li - Clinica Chimica Acta, 2017 - Elsevier
Apelin is the endogenous ligand of the G protein-coupled receptor APJ. Both Apelin and
APJ receptor are widely distributed in various tissues such as heart, brain, limbs, retina and …

Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension

A Jose, JM Elwing, SM Kawut, MW Pauciulo… - Communications …, 2023 - nature.com
Portopulmonary hypertension (PoPH) is a type of pulmonary vascular disease due to portal
hypertension that exhibits high morbidity and mortality. The mechanisms driving disease are …

Therapeutic approaches for treating pulmonary arterial hypertension by correcting imbalanced TGF-β superfamily signaling

P Andre, SR Joshi, SD Briscoe, MJ Alexander… - Frontiers in …, 2022 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a rare disease characterized by high blood
pressure in the pulmonary circulation driven by pathological remodeling of distal pulmonary …

Apelin/APJ system: A potential therapeutic target for endothelial dysfunction‐related diseases

J Cheng, X Luo, Z Huang… - Journal of cellular …, 2019 - Wiley Online Library
APJ is a G protein‐coupled receptor and its endogenous ligand is apelin. Studies have
shown that apelin/APJ system is widely distributed in the body, especially highly expressed …

[PDF][PDF] Current applications of tissue engineering in biomedicine

C Castells-Sala, M Alemany-Ribes… - Journal of Biochips & …, 2013 - researchgate.net
Tissue Engineering (TE) is a scientific field mainly focused on the development of tissue and
organ substitutes by controlling biological, biophysical and/or biomechanical parameters in …